These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23828588)

  • 1. Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.
    Zhong Y; Yan J; Deng M; Hu K; Yao Z; Zou Y; Xu R
    Exp Biol Med (Maywood); 2013 Aug; 238(8):866-73. PubMed ID: 23828588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM; Zhang XF; Li B; Sui CJ; Yang JM
    Ann Surg Oncol; 2014 Jul; 21(7):2406-12. PubMed ID: 24577811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
    Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
    J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
    Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
    Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T; Qin LX; Gong X; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Fan J
    Cancer; 2013 Jan; 119(1):126-35. PubMed ID: 22736338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of cirrhosis on long-term outcomes after liver resection in patients with a single small hepatocellular carcinoma].
    Liang BY; Huang ZY; Liu YA; Hou P; Ji GB; Chen XP
    Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):865-9. PubMed ID: 23302452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver resection for hepatocellular carcinoma in patients without cirrhosis.
    Thelen A; Benckert C; Tautenhahn HM; Hau HM; Bartels M; Linnemann J; Bertolini J; Moche M; Wittekind C; Jonas S
    Br J Surg; 2013 Jan; 100(1):130-7. PubMed ID: 23132620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.
    Sasaki Y; Yamada T; Tanaka H; Ohigashi H; Eguchi H; Yano M; Ishikawa O; Imaoka S
    Ann Surg; 2006 Nov; 244(5):771-80. PubMed ID: 17060771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads.
    Liu WR; Tian MX; Jin L; Yang LX; Ding ZB; Shen YH; Peng YF; Zhou J; Qiu SJ; Dai Z; Fan J; Shi YH
    Ann Surg Oncol; 2015 Mar; 22(3):843-50. PubMed ID: 25269529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
    Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.
    Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP
    J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.